Atlas Trials

Pilot Study of Using Copeptin to Predict Response to Tolvaptan

Clinical trial NCT01346072 · COMPLETED

Trial details

NCT number
NCT01346072
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cardiovascular DiseasesHeart DiseasesHeart Failure
Start date
2011-04-01
Primary completion
2014-02-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.